Lewis H Titterton Jr Buys $132K of Anixa Biosciences Inc (ANIX) — SEC Form 4, Sep 25, 2026
Open-Market Net Purchase · SEC Form 4
+$131,907
Equity position changed by +4.9%
Equity Position
1.05M sh
996,967 → 1,046,003
Equity Change
+4.9%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Lewis H Titterton Jr CIK 0001499254 |
Director
|
Lewis H Titterton Jr at Anixa Biosciences Inc
Full insider history
Bought (12 mo)
$241,348
Sold (12 mo)
—
More from this insider at Anixa Biosciences Inc
| 2026-10-26 | Buy | +$23,840 | View |
| 2026-09-14 | Buy | +$27,300 | View |
| 2026-07-20 | Buy | +$41,640 | View |
| 2026-07-16 | Buy | +$9,174 | View |
| 2026-06-17 | Buy | +$7,487 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-09-23 | P - Purchase | 49,036 A | $2.69 | +$131,907 | 1,046,003 | Direct |
Related filings at Anixa Biosciences Inc
Institutional Holders
13F holders · Sep 30, 2026
75
institutional managers reporting a position
Largest by reported value
- Vanguard Capital Management Llc $3.9M
- Marshall Wace, Llp $2.37M
- Laird Norton Trust Company, Llc $1.76M
5%+ Holders · 13D/G
2 filers
-
Michael Catelani 7.0%
-
Amit Kumar 16.3%
Other insiders at Anixa Biosciences Inc
-
Amit Kumar +$15.9K
-
Amit Kumar +$21.8K
-
Michael Catelani +$15.6K
-
Amit Kumar +$19.5K
-
Arnold M Baskies +$13.8K
GET /v1/forms/4/0001493152-26-044250
API docs
View Original SEC Filing